Stephen Carter
Chief Executive / NeuroScientific Biopharmaceuticals
Stephen Carter has over 30 years of experience within the pharmaceutical and medical device industry. He has held a variety of senior positions with multinationals and public-listed companies including roles as chair, chief executive and managing director.
Mr Carter also has extensive contacts and experience in the financial markets and pharmaceutical industry, in investor and investment management, capital raising, business development and partnering, as well as regulatory and corporate compliance across many global jurisdictions.
Mr Carter has been the chief executive of NeuroScientific Biopharmaceuticals since September 2023. He was chair of Hollista Colltech and DelMedica, and managing director of ASX-listed Solbec Pharmaceuticals.
